The London-based contract research organisation testing vaccines for infectious and respiratory diseases said it will use its RSV human challenge model to test IN-002 in a randomised, double-blinded ...
The Manchester, England-based owner of homeware brands including Salter and Beldray now expects adjusted earnings before interest, tax, depreciation and amortisation for the financial year ending July ...
(Alliance News) - Keystone Positive Change Investment Trust PLC and Baillie Gifford US Growth Trust PLC on Monday said shareholders had rejected proposals by Saba Capital Management LP to oust their ...
Funds under management are anticipated to rise by 17% to GBP1.56 billion from GBP1.34 billion, with Frenkel Topping stating that its progression "continued as expected in the second half". Shares in ...
Dodds also praised the "experience and dynamism" of UK financial services, arguing that Global South investment brings an opportunity for the sector "to marry investment in the economies and ...
3i Infrastructure added it was "on track" to deliver its total dividend target of 12.65 pence per share for financial 2025, up 6.3% from 11.90p last year.
(Alliance News) - The UK's trading relationship with the US is "fair and balanced", Downing Street insisted after Donald Trump said that the UK was "out of line". The prime minister trusts Trump to ...
(Alliance News) - Safestay PLC said its revenue hit a record high in 2024 as occupancy increased and its portfolio expanded against cost-of-living pressures. The London-based hostel operator said in a ...
(Alliance News) - LungLife AI Inc shares collapsed on Monday as it said it would seek shareholder approval to leave the AIM market and anticipates winding-up the company as it is unlikely to receive a ...
(Alliance News) - Polarean Imaging PLC on Monday said it has signed a distribution agreement for its Xenon MRI platform in Taiwan. Shares in the medical imaging technology developer were up 12% at ...
(Alliance News) - Arecor Therapeutics PLC on Monday said its revenue increased in 2024 and said it is excited by the prospects of its "superior insulin candidate". The Cambridgeshire, England-based ...
(Alliance News) - AstraZeneca PLC on Monday said Imfinzi has been recommended for approval in the EU as monotherapy for limited-stage small cell lung cancer.